Back
Supernus Pharmaceuticals Vs. Collegium Pharmaceutical Industry Stock Comparison
Sell
31
SUPN
Supernus Pharmaceuticals
Last Price:
29.25
Seasonality Move:
14.18%
Buy
51
COLL
Collegium Pharmaceutical
Last Price:
33.65
Seasonality Move:
-1.07%
Sell
31
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy, Sell or Hold?
- The current Supernus Pharmaceuticals [SUPN] share price is $28.74. The Score for SUPN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- SUPN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Collegium Pharmaceutical (COLL)
is a Buy
Is Collegium Pharmaceutical a Buy, Sell or Hold?
- The current Collegium Pharmaceutical [COLL] share price is $33.98. The Score for COLL is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- COLL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SUPN Stock Price Chart
What is Supernus Pharmaceuticals's stock price today?
-
The Supernus Pharmaceuticals share price today is $28.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SUPN is experiencing selling pressure, which indicates risk of future bearish movement.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $33.98
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and COLL is experiencing slight selling pressure.
SUPN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 39.72 | Sell |
Chaikin Money Flow: | -306562 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.18 - 30.78) | Sell |
Bollinger Bands (100): | (27.87 - 32.19) | Sell |
COLL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.83 | Sell |
Relative Strength Index (14 RSI): | 41.35 | Sell |
Chaikin Money Flow: | -105988 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.06 - 37.44) | Sell |
Bollinger Bands (100): | (32.44 - 38.04) | Sell |
SUPN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.91 | Sell |
20-day SMA: | 29.94 | Sell |
50-day SMA: | 31.56 | Sell |
200-day SMA: | 29.07 | Sell |
8-day EMA: | 29.58 | Sell |
20-day EMA: | 30.1 | Sell |
50-day EMA: | 30.5 | Sell |
200-day EMA: | 30.2 | Sell |
COLL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.15 | Sell |
20-day SMA: | 35.79 | Sell |
50-day SMA: | 37.26 | Sell |
200-day SMA: | 29.6 | Buy |
8-day EMA: | 34.61 | Sell |
20-day EMA: | 35.69 | Sell |
50-day EMA: | 36.05 | Sell |
200-day EMA: | 31.26 | Buy |
Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.33 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.19 per share, and an increase next year of $0.58 per share.
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.00 per share, an increase this year of $0.76 per share, and an increase next year of $0.70 per share.
Supernus Pharmaceuticals Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Collegium Pharmaceutical Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |